Circular RNAs as emerging regulators in COVID-19 pathogenesis and progression

• Published in: Frontiers in immunology Vol. 13; p. 980231
• Main Authors: Gao, Xiaojun, Fang, Dan, Liang, Yu, Deng, Xin, Chen, Ni, Zeng, Min, Luo, Mao
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 09.11.2022
• Subjects: biological regulator; circRNAs; COVID-19; Immunology; inflammatory response; vaccine
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2022.980231

Coronavirus disease 2019 (COVID-19), an infectious acute respiratory disease caused by a newly emerging RNA virus, is a still-growing pandemic that has caused more than 6 million deaths globally and has seriously threatened the lives and health of people across the world. Currently, several drugs have been used in the clinical treatment of COVID-19, such as small molecules, neutralizing antibodies, and monoclonal antibodies. In addition, several vaccines have been used to prevent the spread of the pandemic, such as adenovirus vector vaccines, inactivated vaccines, recombinant subunit vaccines, and nucleic acid vaccines. However, the efficacy of vaccines and the onset of adverse reactions vary among individuals. Accumulating evidence has demonstrated that circular RNAs (circRNAs) are crucial regulators of viral infections and antiviral immune responses and are heavily involved in COVID-19 pathologies. During novel coronavirus infection, circRNAs not only directly affect the transcription process and interfere with viral replication but also indirectly regulate biological processes, including virus-host receptor binding and the immune response. Consequently, understanding the expression and function of circRNAs during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection will provide novel insights into the development of circRNA-based methods. In this review, we summarize recent progress on the roles and underlying mechanisms of circRNAs that regulate the inflammatory response, viral replication, immune evasion, and cytokines induced by SARS-CoV-2 infection, and thus highlighting the diagnostic and therapeutic challenges in the treatment of COVID-19 and future research directions.